Observation on the Curative Effect of Different Anti-infective Treatment Regimens for Children with Acute

Insights

Three anti-infective regimens showed similar efficacy for pediatric acute appendicitis. Cefminox + Metronidazole is the most economical choice, while Piperacillin-Tazobactam offers the lowest antibiotic intensity to reduce resistance.

Area of Science:

  • Pediatric Surgery
  • Infectious Diseases
  • Pharmacoeconomics

Background:

  • Acute appendicitis is a common surgical emergency in children.
  • Effective anti-infective treatment is crucial for managing appendicitis and preventing complications.
  • Evaluating different antibiotic regimens is important for optimizing patient outcomes and healthcare costs.

Purpose of the Study:

  • To compare the efficacy of three different anti-infective treatment regimens in children with acute appendicitis.
  • To evaluate postoperative recovery, treatment effectiveness, bacterial clearance, complication rates, and pharmacoeconomic aspects.
  • To identify the most suitable and cost-effective treatment strategy.

Main Methods:

  • Retrospective study of 90 children undergoing laparoscopic appendectomy (May 2020 - September 2022).
  • Patients were divided into three groups receiving Piperacillin-Tazobactam, Piperacillin-Tazobactam + Metronidazole, or Cefminox + Metronidazole preoperatively.
  • Comparison of clinical outcomes, microbiological data, complication rates, pharmacoeconomics, and adverse reactions.

Main Results:

  • All three regimens demonstrated comparable effective rates (83.33% - 90.00%) with no significant differences in bacterial clearance, complication incidence, or side effects.
  • The Cefminox + Metronidazole group showed significantly lower total hospitalization, drug, and antimicrobial costs compared to the other two groups.
  • Piperacillin-Tazobactam group exhibited the lowest intensity of antibacterial drug use.

Conclusions:

  • Cefminox + Metronidazole is a cost-effective and preferred regimen for pediatric acute appendicitis due to its economic advantages.
  • Piperacillin-Tazobactam may be considered for its lower antibiotic intensity, potentially reducing the risk of bacterial resistance.
  • All evaluated anti-infective regimens provide similar therapeutic effects for acute appendicitis in children.
Abstract

Related Concept Videos

Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
74
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
113
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
117
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
157
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
110
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
363